Enovix Q2 Revenue Surpasses Guidance, Doubles YoY; GAAP Net Loss Improves to $43.3M; EPS at Favorable End of Forecast

Reuters
07 Jul
Enovix <a href="https://laohu8.com/S/QTWO">Q2</a> Revenue Surpasses Guidance, Doubles YoY; GAAP Net Loss Improves to $43.<a href="https://laohu8.com/S/MMM">3M</a>; EPS at Favorable End of Forecast

Enovix Corporation announced its preliminary unaudited financial results for the second quarter ended June 29, 2025. The company's revenue reached $7.5 million, surpassing its guidance range of $4.5 million to $6.5 million and nearly doubling from the $3.8 million reported in the second quarter of 2024. This increase was driven by rising customer demand across multiple end markets. The GAAP Gross Profit stood at $0.8 million, with a non-GAAP Gross Profit of $1.2 million, marking a positive shift from the previous year's second-quarter gross losses of $0.7 million and $0.6 million, respectively. Enovix reported a GAAP Operating Loss of $43.8 million and a non-GAAP Operating Loss of $27.8 million, better than its guidance range of $31 million to $37 million and an improvement from the $88.8 million GAAP Operating Loss reported in the second quarter of 2024. The GAAP Net Loss attributable to Enovix was $43.3 million, down from $115.9 million in the same period last year. On a non-GAAP basis, the net loss was $28.4 million, compared to $24.9 million in the previous year. The Adjusted EBITDA Loss narrowed to $21.4 million, ahead of the forecasted range of $23 million to $29 million. Cash, cash equivalents, and short-term investments were approximately $203 million as of June 29, 2025. This included the completion of the SolarEdge asset acquisition in South Korea and other capital expenditure payments primarily related to Fab2. The company continues to build momentum and is positioned for significant scaling with the introduction of new products and customers. Enovix will provide final results in its upcoming Q2 2025 earnings call and webcast scheduled for late July or early August.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enovix Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9489917-en) on July 07, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10